The latest Gluten-Free Brief covers new research and guidance on celiac disease, including diagnostic delays in Canada, Poland’s national guidelines, complications among adults with both celiac disease and type 2 diabetes, and new findings on biopsy interpretation and celiac blood-test systems. We also look at recent gluten and allergen recalls in Spain, Canada, Australia and the UK.
Many Canadians with celiac disease waited years for a diagnosis.
Among 6,260 respondents to a nationwide Celiac Canada survey, nearly 70% reported more than two years between symptom onset and diagnosis, while lower income was linked to greater difficulty following a gluten-free diet.
Source: Journal of the Canadian Association of Gastroenterology, September 2026.
Poland has published national guidelines for celiac disease.
The recommendations cover diagnosis, treatment and follow-up, allowing a biopsy-free pathway in selected adults under 45 with anti-TG2 IgA at least 10 times the upper limit of normal, a positive second sample and no alarm symptoms.
Source: Gastroenterology Review, October 2026.
Pathologists don’t always agree when interpreting celiac biopsies.
A review of 23 studies found less agreement when grading intestinal damage, with expertise and sample quality also affecting results, supporting an approach that combines biopsy findings with blood tests and clinical information.
Source: Journal of Clinical Pathology, September 2026.
The same cutoff may not work for every celiac blood-test system.
In a selected group of 84 children, three systems measuring the same antibody performed differently at the cutoff used in biopsy-free diagnosis, supporting validation of the cutoff for each testing system.
Source: Immunologic Research, October 2026.
Celiac disease was linked to more complications in adults with type 2 diabetes.
In a matched study of 17,520 adults, those with both conditions had higher risks of nerve, eye and kidney complications, although the observational findings do not establish causation.
Source: Endocrine, September 2026.
Four recalls flag gluten and allergen-labeling risks.
Spain warned of gluten in Santiveri BIO buckwheat crispbreads labeled gluten free; alerts also cover Canada’s Taeyangcho Gochujang (hot pepper paste), Australia’s Da Chả Giò Rế Net wrappers and the UK’s Lambertz Mini Spekulatius and Christmas Tree Cookies.
Sources: AESAN; CFIA; FSANZ; UK FSA, October 2026.
The Gluten-Free Brief is a twice-monthly informational news roundup from the Gluten-Free Food Program. It is provided for educational purposes and does not replace medical advice from qualified professionals. Inclusion of any product, brand, or organization does not imply endorsement by GFFP. Previous editions can be found here and on our LinkedIn, Instagram, and TikTok. Stay informed. Stay safe.
